PROKProKidney Corp.
$1.67-44% 1Y
$1.67
$1.3352 weeks$3.30
PROK in its own filings
PROK's filing record carries 3 kinds of hard flag, each is shown beside the share of the whole market carrying the same one, because more than half of all companies carry at least one.
121
Events found in the filings · across 397 filings · the record starts in 2021
- Hard flags
- 3
Hard flags
- Most recent filing
- Aug 10, 2026
Most recent filing · Form 8-K
- Record starts
- Jun 15, 2021
Record starts · the earliest filing Ryufin holds for this name
Details›
- Next results filingsame week as a year ago
- expected around Nov 9, 2026
- Restatement admitted (non-reliance)historical
- 2021-11-16
- Change in certifying accountanthistorical
- 2022-07-15
- Delisting notice / listing-rule failurehistorical
- 2022-07-12
- SEC comment-letter activity16 occurrences
- 2025-04-24
SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.
What the company said
The company's own words from its current reports to the SEC, newest first
- Aug 10, 2026ProKidney Reports Second Quarter 2026 Financial Results and Business Highlights.Earnings release · press release
- May 15, 2026The statistical powering assumption for the surrogate endpoint (eGFR slope) analysis in the PROACT 1 study has been updated to 80%, while the statistical powering assumption for the confirmatory endpoint analysis remains at 80%.Earnings release · Form 8-K
- Mar 18, 2026ProKidney Reports Full Year 2025 Financial Results and Business Highlights.Earnings release · press release
- Feb 2, 2026The information set forth in the second paragraph of.Regulation FD disclosure · Form 8-K
- Jan 12, 2026Advanced CKD Patients Want More Time More time before dialysis More time for life’s moments More time and flexibility with the people who matter most Time for Hope.Regulation FD disclosure · press release
- Nov 10, 2025ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates.Earnings release · press release
- Oct 17, 2025As previously disclosed, on May 8, 2025, ProKidney Corp. (the “Company”), through its wholly owned subsidiary, ProKidney Acquisition Company, LLC (“Acquisition Sub”), entered into a purchase and sale agreement with Williams Development Group, LLC (the “Williams Purchase Agreement”) to sell the Company’s property …Material agreement entered · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
opening the record…
Biotechnology
The closest names by size in the same industry